Showing results (261-270 of 471) with videos related to

Sort By:
Pageof 48
Epidemiology and Infection|May 11, 2006
The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonalK A Talukder, B K Khajanchi, M A Islam, et al.
The Journal of Infectious Diseases|November 17, 2006
Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12Richard L Ward, Carl D Kirkwood, Donna S Sander, et al.
Plos Neglected Tropical Diseases|May 17, 2023
Prioritizing interventions for cholera control in Kenya, 2015-2020Waqo Boru, Shaoming Xiao, Patrick Amoth, et al.
Clinical and Vaccine Immunology : CVI|February 12, 2016
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult SubjectsSubhra Chakraborty, Clayton Harro, Barbara DeNearing, et al.
Microbial Pathogenesis|March 13, 2012
Activation of p53/ATM-dependent DNA damage signaling pathway by shiga toxin in mammalian cellsKaisar A Talukder, Ishrat J Azmi, K Ahtesham Ahmed, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2006
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibioticRubhana Raqib, Protim Sarker, Peter Bergman, et al.
Journal of Clinical Microbiology|April 16, 1999
Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in BangladeshS M Faruque, A K Siddique, M N Saha, et al.
Current Microbiology|February 2, 2006
Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1Kaisar A Talukder, Bijay K Khajanchi, Mohammad A Islam, et al.
The American Journal of Gastroenterology|June 18, 2003
Therapy of travelers' diarrhea with rifaximin on various continentsRobert Steffen, David A Sack, Lise Riopel, et al.
Pageof 48